-+ 0.00%
-+ 0.00%
-+ 0.00%

U.S. FDA GRANTS PRIORITY REVIEW FOR GENENTECH’S ENSPRYNG FOR MOGAD, AN AUTOIMMUNE DISEASE WITH NO APPROVED TREATMENTS

Reuters·09/10/2026 05:11:00

Please log in to view news